UCC Division of Oncological, Transplant and General Surgery
Gdansk, Pomeranian Voivodeship, 80952, Poland
NCT Number: NCT05684198
The study aims to evaluate the efficacy of negative pressure wound therapy (NPWT) compared with primary closure (PC) in surgical site infection (SSI) prevention for laparotomy for peritonitis.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Gdansk, Pomeranian Voivodeship, 80952, Poland
Surgical site infection is a particularly common morbidity in contaminated surgeries leading to prolonged length of hospital stay, healing time, and a significant financial burden on healthcare systems.
Hence, the objective of PRISTINE trial is to compare the effectiveness of subcutaneous NPWT with PC for SSI prevention in patients who, due to wound contamination, are prone to infection. Moreover, with a further cost analysis, the investigators aim to evaluate the rationale for the implementation of routine preventive NPWT for laparotomy for diffuse peritonitis.
Patients qualified for an emergency laparotomy for peritonitis in University Clinical Centre (UCC) Division of Oncological, Endocrine and General Surgery will be identified. Prior to laparotomy, participants will be randomized in 1:1 ratio to subcutaneous NPWT or PC. The assigned intervention will be performed intraoperatively, after fascia closure.
All participants will receive an empirical antibiotic therapy regimen consisting of tazobactam/piperacillin or ciprofloxacin+ metronidazole. Participants will be followed-up postoperatively for one year.
In case of an SSI all participants, regardless of their initial allocation, will be treated according to the standard of care with prolonged NPWT and targeted antibiotic therapy.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Following fascia closure, NPWT system will be inserted into subcutaneous tissue, continuous negative pressure of 120 mmHg will be applied.
Other names: vacuum-assisted wound closure, Vivano, Renasys
Time frame: 30 days
definitive wound closure, not followed by secondary wound dehiscence
Time frame: 1 year
Time of last out-patient visit ending the process of treating surgical wound
Time frame: 90 days
postoperative length of hospital stay
Time frame: 120 days
time to full epithelialisation of the wound
Time frame: 60 days
Volume of wound drainage collected in a NPWT or drainage collector
Time frame: 60 days
Duration of NPWT therapy administered if SSI occured
Time frame: 60 days
occurrence of adverse events and complications following surgery measured with Clavien-Dindo scale (grade I to V; grade I represents any deviation from the normal post-operative course not requiring surgical, endoscopic or radiological intervention and grade 5 represents patient's death)
Time frame: 30 days
Surgical Site Infection according to Centre for Disease Control (CDC) criteria:
Infection occurring within the first 30 post-operative days with at least one of the following:
Due to the inability to implement CDC for wounds treated with NPWT, the investigators have included additional SSI criteria: the absolute necessity to prolong NPWT after 3rd day postop, an anergic wound morphology or slough.
Time frame: 7 days
Pain measured with Visual Analogue Scale every 8h (subjective pain strength scale from 0 to 10; 0 represents no pain and 10 represents the worst pain)
Time frame: 1 year
Measured with Vancouver Scar Scale (VSS). This scale ranges from 0 (representing normal skin) to 13 (representing worst scar imaginable). VSS provides the assessment of the following wound characteristics: pigmentation (0-2), vascularity (0-3), pliability (0-5), height (0-3).
Time frame: 1 year
Cost of hospitalisation and outpatient visits
Medical University of Gdansk
Other
Emergency Laparotomy for Peritonitis and Surgical Site Infection: Preventive Subcutaneous NPWT vs Primary Closure - a Randomized Health Services Study
Acronym: PRISTINE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07531576
Delayed Primary Closure, Digestive System Diseases
Abbottabad, KPK, Pakistan
View Trial DetailsNCT02882932
Digestive System Diseases, Infections
View Trial DetailsNCT00692393
Digestive System Diseases, Infections
Rouen, France
View Trial DetailsNCT04577339
Abdomen, Acute, Abdominal Pain
Portsmouth, Hampshire, United Kingdom
View Trial Details